Sep 15, 2020 / NTS GMT
Operator
Welcome to the Virtual Road Show series presented by Channelchek and Noble Capital Markets.
Of the 6,000 small and microcap companies hosted on Channelchek, today we're featuring Genprex, Nasdaq ticker symbol GNPX. Research coverage of Genprex is provided by Noble Capital Markets. Noble is a FINRA-licensed, SEC-registered broker dealer. All Noble research is available on Channelchek.
Following the formal presentation, Ahu Demir, Noble's Biotechnology Research Analyst covering Genprex will ask our presenter, a selection of the questions received. The source of the questions will remain anonymous. And now here's Rodney Varner, CEO of Genprex to make the presentation. Rodney, take it away.
Rodney Varner - Genprex, Inc. - Chairman, President & CEO
Okay, thanks very much. Thanks to Noble for giving me the opportunity to present today. I'm Rodney Varner, Founder, Chairman, and CEO of Genprex.
At Genprex, we're reprogramming the course of cancer and diabetes through gene therapies. I know that this audience has seen the forward-looking
Genprex (GNPX) Virtual Road Show with CEO Rodney Varner Transcript
Sep 15, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers